Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure. - Merrill MH; Redd RA; Lambert N; Caimi PF; Pullarkat P; Godby RC; Bond DA; Wehmeyer GT; Romancik J; Amoozgar B; Leslie L; Nastoupil LJ; et al. (HemaSphere, 2025)